Abstract
A novel computational technology based on fragmentation of the chemical compounds has been used for the fast and efficient prediction of activities of prospective protease inhibitors of the hepatitis C virus. This study spans over a discovery cycle from the theoretical prediction of new HCV NS3 protease inhibitors to the first cytotoxicity experimental tests of the best candidates. The measured cytotoxicity of the compounds indicated that at least two candidates would be suitable further development of drugs.
Keywords: Fragment QSAR, multilinear regression, hepatitis C, HCV protease inhibitors, viral replication, cytotoxicity, CoMFA, CoMSIA, topological descriptors, SAR
Current Computer-Aided Drug Design
Title: Fragment-Based Development of HCV Protease Inhibitors for the Treatment of Hepatitis C
Volume: 8 Issue: 1
Author(s): Mati Karelson, Dimitar A. Dobchev, Gunnar Karelson, Tarmo Tamm, Kaido Tamm, Andrei Nikonov, Margit Mutso and Andres Merits
Affiliation:
Keywords: Fragment QSAR, multilinear regression, hepatitis C, HCV protease inhibitors, viral replication, cytotoxicity, CoMFA, CoMSIA, topological descriptors, SAR
Abstract: A novel computational technology based on fragmentation of the chemical compounds has been used for the fast and efficient prediction of activities of prospective protease inhibitors of the hepatitis C virus. This study spans over a discovery cycle from the theoretical prediction of new HCV NS3 protease inhibitors to the first cytotoxicity experimental tests of the best candidates. The measured cytotoxicity of the compounds indicated that at least two candidates would be suitable further development of drugs.
Export Options
About this article
Cite this article as:
Karelson Mati, A. Dobchev Dimitar, Karelson Gunnar, Tamm Tarmo, Tamm Kaido, Nikonov Andrei, Mutso Margit and Merits Andres, Fragment-Based Development of HCV Protease Inhibitors for the Treatment of Hepatitis C, Current Computer-Aided Drug Design 2012; 8 (1) . https://dx.doi.org/10.2174/157340912799218516
DOI https://dx.doi.org/10.2174/157340912799218516 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours
Recent Patents on CNS Drug Discovery (Discontinued) Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes
Current Pharmaceutical Design Building Early Intervention Services for Psychotic Disorders: A Primer for Early Adopters in the U.S.
Current Psychiatry Reviews Survey of Epstein Barr Virus (EBV) Immunogenic Proteins and their Epitopes: Implications for Vaccine Preparation
Recent Patents on Anti-Infective Drug Discovery Ligands of Diltiazem Binding Site: An Overview of Some Chemotypes
Mini-Reviews in Medicinal Chemistry Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis
Current Neuropharmacology Beta-Blockers in Children with Congenital Heart Disease Before a Corrective Procedure
Reviews on Recent Clinical Trials Stationary Wavelet Transform and AdaBoost with SVM Based Pathological Brain Detection in MRI Scanning
CNS & Neurological Disorders - Drug Targets 1,4-Benzothiazines-A Biologically Attractive Scaffold
Mini-Reviews in Medicinal Chemistry Proteome and Metabolome Alterations in Heart and Liver Indicate Compromised Energy Production During Sepsis
Protein & Peptide Letters Iron Overload and Glucose Metabolism in Subjects with β-thalassaemia Major : An Overview
Current Diabetes Reviews From the Prodrome to Chronic Schizophrenia: The Neurobiology Underlying Psychotic Symptoms and Cognitive Impairments
Current Pharmaceutical Design 58-Year Old Men with Non-Stenotic Carotid Artery Plaques and the Relationship with Cardiovascular Risk Factors and Future Cardiovascular Events
Vascular Disease Prevention (Discontinued) Processing and Regulation Mechanisms within Antigen Presenting Cells: A Possibility for Therapeutic Modulation
Current Pharmaceutical Design Polyphenols and Aging
Current Aging Science Nutrition and Nutraceuticals in Neuroinflammatory and Brain Metabolic Stress: Implications for Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Selection: Critical Analyses of Mechanism-Based Therapies Against Parkinson’s Disease: Concepts and Perspectives)
Current Neuropharmacology Phytosterols: Perspectives in Human Nutrition and Clinical Therapy
Current Medicinal Chemistry Use of fMRI and Structural Equation Modeling for Studying Interconnected Brain Areas within a Hypothetical Network
Current Medical Imaging Molecular Mechanisms Underlying St. Johns Wort Drug Interactions
Current Drug Metabolism